Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.00 (0.00%)
Bid:
1.20
Ask:
1.28
Spread: 0.08 (6.667%)
Market Cap: $21.21m
JPEL Live PriceLast checked at - London Stock Exchange

Intraday Jpel Priv Eqty Share Chart

2025 AGM Results Statement

2 Dec 2025 16:44

RNS Number : 9471J
JPEL Private Equity Limited
02 December 2025
 

JPEL Private Equity Limited

Fourth Floor

Plaza House

Admiral Park, St Peter Port

Guernsey, GY1 4BF

www.jpelonline.com

 

 

JPEL ANNOUNCES RESULTS OF AGM

AND BOARD SUCCESSION

 

 

* * *

 

GUERNSEY, 2 DECEMBER 2025

 

JPEL Private Equity Limited (the "Company") announces that at the Annual General Meeting ("AGM") of the Company held on 2 December 2025, all resolutions put to shareholders at the AGM were duly passed.

 

SUMMARY OF RESOLUTIONS PROPOSED AT AGM

 

 

Special Resolutions

1. To renew the Company's authority to make purchases of up to 15 per cent. of its own issued US$ Equity Shares pursuant to any proposed Tender Offer.

2. To renew the Company's general authority to make market purchases of up to 14.99 per cent. of the US$ Equity Shares.

 

Ordinary Resolutions

3. To approve and adopt the Annual Report and Financial Statements of the Company for the year ended 30 June 2025.

4. To re-elect PricewaterhouseCoopers CI LLP as Auditors to the Company.

5. To re-authorise the Directors to determine the Auditors' remuneration.

6. To re-authorise and agree the remuneration of the Directors in accordance with the Articles of Incorporation.

7. To re-elect Trina Le Noury as a non-executive, independent director of the Company.

8. To re-elect Anthony (Tony) Dalwood as a non-executive, independent director of the Company.

 

 

 

Below, please find a summary of all votes received for JPEL's AGM: 

 

In Favour

Discretion

Against

Withheld

Resolution

Votes

%

Items

Votes

%

Items

Votes

%

Items

Votes

Items

1

15,561,578

100

14

0

0

0

0

0

0

496,448

1

2

15,561,578

100

14

0

0

0

0

0

0

496,448

1

3

15,561,578

100

14

0

0

0

0

0

0

496,448

1

4

15,561,578

100

14

0

0

0

0

0

0

496,448

1

5

15,561,578

100

14

0

0

0

0

0

0

496,448

1

6

15,561,578

100

14

0

0

0

0

0

0

496,448

1

7

15,335,078 

98.54

13

0

0

0

226,500

1.46

1

496,448

1

8

12,233,887 

78.62

12

0

0

0

3,327,691

21.38

2

496,448

1

 

NB: Percentage of Votes cast excludes Withheld votes and resolution 9 (relating to the re-election of Sean Hurst) was withdrawn from the meeting. The Board acknowledges that there was a significant minority vote (being in excess of 20 per cent) against resolution 8, and will duly engage with shareholders in relation to this matter.

 

* * *

 

 Board Succession

In light of two of the three Board directors having served for at least nine years a process is underway to refresh its configuration. In order to ensure an orderly Board succession plan, this process is anticipated to be completed within six months. The Board remains mindful of its fiduciary duties to all shareholders including its commitment to focus on minimising costs appropriately. 

 

As a first stage of this orderly transition, Sean Hurst had notified the Company of his intention to step-down from his position prior to the AGM with immediate effect. The Board and Manager would like to thank Sean for his valuable contribution during his time as Chair and wish him all the best in his future endeavours.

 

Tony Dalwood has been appointed Chair with immediate effect to oversee the succession plan. Trina Le Noury remains Chair of the Audit committee.

 

The appointment of additional Non-Executive Directors is progressed and, subject to completion of the relevant regulatory approvals, at least one new Director will join the Board shortly. A further update will be provided in due course.

 

About JPEL Private Equity Limited

JPEL Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well-diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.

 

ENQUIRIES:

 

FCF JPEL Management LLC

JPELClientService@fortress.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGQLLFBELLZFBX
Date   Source Headline
18th Nov 20207:00 amRNSStatement re Company Update
13th Nov 20202:49 pmRNSNet Asset Value - August 2020
9th Nov 20204:43 pmRNSNet Asset Value - July 2020
4th Nov 20209:35 amRNS2020 AGM CIRCULAR
8th Oct 20207:00 amRNSAnnual Financial Report - 30 June 2020
16th Sep 202011:55 amRNSNet Asset Value - June 2020
31st Jul 20203:05 pmRNSNet Asset Value - May 2020
24th Jun 20207:00 amRNSNet Asset Value - April 2020
10th Jun 202011:04 amRNSNet Asset Value - March 2020
24th Apr 20207:00 amRNSNet Asset Value - February 2020
14th Apr 20204:47 pmRNSNet Asset Value - January 2020
14th Apr 20203:35 pmRNSNet Asset Value - January 2020
14th Apr 20203:16 pmRNSHolding(s) in Company
1st Apr 20205:35 pmRNSReplacement Completion of 7th Mandatory Redemption
1st Apr 20203:33 pmRNSCompletion of Seventh Mandatory Redemption
25th Mar 20207:00 amRNSSeventh Mandatory Redemption
17th Mar 20203:46 pmRNSHalf-year Report - 31 December 2019
13th Mar 20207:00 amRNSPartial Sale of 2nd Largest Investment
6th Mar 20204:51 pmRNSNet Asset Value(s) - December 2019
10th Jan 20203:21 pmRNSNet Asset Value - November 2019
5th Dec 20194:56 pmRNSNet Asset Value(s) - October 2019
26th Nov 20197:00 amRNSAGM Results 2019
15th Nov 20196:23 pmRNSNet Asset Value(s) - September - Replacement
15th Nov 20195:52 pmRNSNet Asset Value(s) - September
15th Nov 20195:51 pmRNSNet Asset Value(s) - August 2019
15th Nov 20195:51 pmRNSNet Asset Value(s) - July 2019
5th Nov 20195:42 pmRNS2019 AGM CIRCULAR
22nd Oct 20197:00 amRNSCompletion of Sixth Mandatory Redemption
9th Oct 20193:28 pmRNSSixth Mandatory Redemption
27th Sep 201910:48 amRNSAnnual Financial Report - 30 June 2019
10th Sep 20191:19 pmRNSNet Asset Value(s) - June 2019
12th Jul 20197:00 amRNSNet Asset Value(s) - May 2019
13th Jun 20197:00 amRNSNet Asset Value(s) - April 2019
17th May 20197:00 amRNSNet Asset Value(s) - March 2019
5th Apr 20197:00 amRNSNet Asset Value(s) - February 2019
19th Mar 20193:57 pmRNSHalf-year Report - 31 December 2018
13th Mar 20197:00 amRNSNet Asset Value(s)
7th Feb 201910:55 amRNSNet Asset Value(s) - December 2018
22nd Jan 201910:10 amRNSNet Asset Value(s) - November 2018
8th Jan 20197:00 amRNSCompletion Of Fifth Mandatory Redemption
10th Dec 20183:58 pmRNSMandatory Redemption - US$Equity Shares - Dec 2018
6th Dec 20183:28 pmRNSHolding(s) in Company
30th Nov 20183:21 pmRNSNet Asset Value(s) - October 2018
27th Nov 201811:08 amRNSAGM Results 2018
7th Nov 20187:00 amRNS2018 AGM CIRCULAR
30th Oct 20187:00 amRNSNet Asset Value(s) - September 2018
30th Oct 20187:00 amRNSNet Asset Value(s) - August 2018
30th Oct 20187:00 amRNSNet Asset Value(s) - July 2018
12th Oct 20184:32 pmRNSHolding(s) in Company
4th Oct 20182:42 pmRNSNotification of Dealings in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.